The Coronary Drug Project was carried out to evaluate the efficacy and safety of several lipid-influencing drugs in the long-term treatment of coronary heart disease. The five-year mortality in 1103 men treated with clofibrate was 20.0 per cent, as compared with 20.9 per cent in 2789 men given placebo (P = 0.55). Good adherers to clofibrate, i.e., patients who took 80 per cent of more of the protocol prescription during the five-year follow-up period, had a substantially lower five-year mortality than did poor adherers to clofibrate (15.0 vs. 24.6 per cent; P = 0.00011). However, similar findings were noted in the placebo group, i.e., 15.1 per cent mortality for good adherers and 28.3 per cent for poor adherers (P = 4.7x10-16). These findings and various other analyses of mortality in the clofibrate and placebo groups of the project show the serious difficulty, if not impossibility, of evaluating treatment efficacy in subgroups determined by patient responses (e.g., adherence or cholesterol change) to the treatment protocol after randomization.
This article has been cited by other articles:
Han, M. K
(2009). Medication adherence in COPD: what have we learned?. Thorax
64: 922-923
[Full Text]
Nuesch, E., Trelle, S., Reichenbach, S., Rutjes, A. W S, Burgi, E., Scherer, M., Altman, D. G, Juni, P.
(2009). The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ
339: b3244-b3244
[Abstract][Full Text]
Sansbury, L. B., Wanke, K., Albert, P. S., Kahle, L., Schatzkin, A., Lanza, E., the Polyp Prevention Trial Study Group,
(2009). The Effect of Strict Adherence to a High-Fiber, High-Fruit and -Vegetable, and Low-Fat Eating Pattern on Adenoma Recurrence. Am J Epidemiol
170: 576-584
[Abstract][Full Text]
Ho, P. M., Bryson, C. L., Rumsfeld, J. S.
(2009). Medication Adherence: Its Importance in Cardiovascular Outcomes. Circulation
119: 3028-3035
[Abstract][Full Text]
Golomb, B. A., Koperski, S.
(2009). Association Not Causation. Arch Intern Med
169: 1079-1079
[Full Text]
Shalev, V., Chodick, G.
(2009). Continuation of Statin Treatment and Mortality: A Note of Caution on Excessive Benefits--Reply. Arch Intern Med
169: 1080-1081
[Full Text]
Raymond, S., Favilla, I., Santamaria, L.
(2009). Comparing Ultrasound Biometry with Partial Coherence Interferometry for Intraocular Lens Power Calculations: A Randomized Study. IOVS
50: 2547-2552
[Abstract][Full Text]
Huss, A. PhD, Scott, P. MSc, Stuck, A. E. MD, Trotter, C. PhD, Egger, M. MD MSc
(2009). Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ
180: 48-58
[Abstract][Full Text]
Kritchevsky, S. B
(2008). "Adherence bias" in nutritional epidemiology. Am. J. Clin. Nutr.
88: 1448-1449
[Full Text]
McPherson, K.
(2008). Do patients' preferences matter?. BMJ
337: a2034-a2034
[Full Text]
Suissa, S., Ernst, P., Vandemheen, K. L., Aaron, S. D.
(2008). Methodological issues in therapeutic trials of COPD. Eur Respir J
31: 927-933
[Abstract][Full Text]
Jackevicius, C. A., Li, P., Tu, J. V.
(2008). Prevalence, Predictors, and Outcomes of Primary Nonadherence After Acute Myocardial Infarction. Circulation
117: 1028-1036
[Abstract][Full Text]
Ho, P. M., Magid, D. J., Shetterly, S. M., Olson, K. L., Peterson, P. N., Masoudi, F. A., Rumsfeld, J. S.
(2008). Importance of Therapy Intensification and Medication Nonadherence for Blood Pressure Control in Patients With Coronary Disease. Arch Intern Med
168: 271-276
[Abstract][Full Text]
Frenkel, O.
(2008). A Phenomenology of the 'Placebo Effect': Taking Meaning from the Mind to the Body. J Med Philos
33: 58-79
[Abstract][Full Text]
Streiner, D. L
(2008). Missing data and the trouble with LOCF. Evid. Based Ment. Health
11: 3-5
[Full Text]
Shumway-Cook, A., Silver, I. F., LeMier, M., York, S., Cummings, P., Koepsell, T. D.
(2007). Effectiveness of a Community-Based Multifactorial Intervention on Falls and Fall Risk Factors in Community-Living Older Adults: A Randomized, Controlled Trial. Journals of Gerontology Series A: Biological Sciences and Medical Sciences
62: 1420-1427
[Abstract][Full Text]
Gehi, A. K., Ali, S., Na, B., Whooley, M. A.
(2007). Self-reported Medication Adherence and Cardiovascular Events in Patients With Stable Coronary Heart Disease: The Heart and Soul Study. Arch Intern Med
167: 1798-1803
[Abstract][Full Text]
Schneeweiss, S., Patrick, A. R., Maclure, M., Dormuth, C. R., Glynn, R. J.
(2007). Adherence to Statin Therapy Under Drug Cost Sharing in Patients With and Without Acute Myocardial Infarction: A Population-Based Natural Experiment. Circulation
115: 2128-2135
[Abstract][Full Text]
Stanley, K.
(2007). Evaluation of Randomized Controlled Trials. Circulation
115: 1819-1822
[Full Text]
Cepeda, M. S., Carr, D. B., Sarquis, T., Miranda, N., Garcia, R. J., Zarate, C.
(2007). Static Magnetic Therapy Does Not Decrease Pain or Opioid Requirements: A Randomized Double-Blind Trial. Anesth. Analg.
104: 290-294
[Abstract][Full Text]
Olshansky, B.
(2007). Placebo and Nocebo in Cardiovascular Health: Implications for Healthcare, Research, and the Doctor-Patient Relationship. J Am Coll Cardiol
49: 415-421
[Abstract][Full Text]
Ziegelstein, R. C., Miller, S. D.
(2006). Just a Spoonful of Sugar. J Am Coll Cardiol
48: 2223-2224
[Full Text]
Appel, L. J.
(2006). A Primer on the Design, Conduct, and Interpretation of Clinical Trials. CJASN
1: 1360-1367
[Abstract][Full Text]
Hayward, R. A., Hofer, T. P., Vijan, S.
(2006). Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem.. ANN INTERN MED
145: 520-530
[Abstract][Full Text]
Glasser, S. P., Howard, G.
(2006). Clinical trial design issues: at least 10 things you should look for in clinical trials.. J Clin Pharmacol
46: 1106-1115
[Abstract][Full Text]
Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., Magid, D. J.
(2006). Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus.. Arch Intern Med
166: 1836-1841
[Abstract][Full Text]
Ho, P. M., Spertus, J. A., Masoudi, F. A., Reid, K. J., Peterson, E. D., Magid, D. J., Krumholz, H. M., Rumsfeld, J. S.
(2006). Impact of medication therapy discontinuation on mortality after myocardial infarction.. Arch Intern Med
166: 1842-1847
[Abstract][Full Text]
Walker, E. A., Molitch, M., Kramer, M. K., Kahn, S., Ma, Y., Edelstein, S., Smith, K., Johnson, M. K., Kitabchi, A., Crandall, J., for the Diabetes Prevention Program Research Group,
(2006). Adherence to Preventive Medications: Predictors and outcomes in the Diabetes Prevention Program.. Diabetes Care
29: 1997-2002
[Abstract][Full Text]
Li, B., Grambsch, P.
(2006). Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event. Clin Trials
3: 349-359
[Abstract]
Wittes, J.
(2006). A tale of three species rabbits, chickens and humans: an interview with clinical trials pioneer Jeremiah Stamler. Clin Trials
3: 320-334
Newby, L. K., Allen LaPointe, N. M., Chen, A. Y., Kramer, J. M., Hammill, B. G., DeLong, E. R., Muhlbaier, L. H., Califf, R. M.
(2006). Long-Term Adherence to Evidence-Based Secondary Prevention Therapies in Coronary Artery Disease. Circulation
113: 203-212
[Abstract][Full Text]
Praska, J. L, Kripalani, S., Seright, A. L, Jacobson, T. A
(2005). Identifying and Assisting Low-Literacy Patients with Medication Use: A Survey of Community Pharmacies. The Annals of Pharmacotherapy
39: 1441-1445
[Abstract][Full Text]
Osterberg, L., Blaschke, T.
(2005). Adherence to Medication. NEJM
353: 487-497
[Full Text]
White, I. R
(2005). Uses and limitations of randomization-based efficacy estimators. Stat Methods Med Res
14: 327-347
[Abstract]
Vogel, J. H.K., Bolling, S. F., Costello, R. B., Guarneri, E. M., Krucoff, M. W., Longhurst, J. C., Olshansky, B., Pelletier, K. R., Tracy, C. M., Vogel, R. A., Vogel, R. A., Abrams, J., Anderson, J. L., Bates, E. R., Brodie, B. R., Grines, C. L., Danias, P. G., Gregoratos, G., Hlatky, M. A., Hochman, J. S., Kaul, S., Lichtenberg, R. C., Lindner, J. R., O'Rourke, R. A., Pohost, G. M., Schofield, R. S., Shubrooks, S. J., Tracy, C. M., Winters, W. L. Jr
(2005). Integrating Complementary Medicine Into Cardiovascular Medicine: A Report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). J Am Coll Cardiol
46: 184-221
[Full Text]
Shemesh, E., Yehuda, R., Milo, O., Dinur, I., Rudnick, A., Vered, Z., Cotter, G.
(2004). Posttraumatic Stress, Nonadherence, and Adverse Outcome in Survivors of a Myocardial Infarction. Psychosom. Med.
66: 521-526
[Abstract][Full Text]
Lett, H. S., Blumenthal, J. A., Babyak, M. A., Sherwood, A., Strauman, T., Robins, C., Newman, M. F.
(2004). Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment. Psychosom. Med.
66: 305-315
[Abstract][Full Text]
McPherson, K., Hemminki, E.
(2004). Synthesising licensing data to assess drug safety. BMJ
328: 518-520
[Full Text]
Stradling, J.
(2004). Con: Sleep Apnea Does Not Cause Cardiovascular Disease. Am. J. Respir. Crit. Care Med.
169: 148-149
[Full Text]
Garbe, E., Suissa, S.
(2004). Issues to debate on the Women's Health Initiative (WHI) study: Hormone replacement therapy and acute coronary outcomes: methodological issues between randomized and observational studies. Hum Reprod
19: 8-13
[Abstract][Full Text]
Col, N. F., Pauker, S. G.
(2003). The Discrepancy between Observational Studies and Randomized Trials of Menopausal Hormone Therapy: Did Expectations Shape Experience?. ANN INTERN MED
139: 923-929
[Abstract][Full Text]
Ray, W. A.
(2003). Evaluating Medication Effects Outside of Clinical Trials: New-User Designs. Am J Epidemiol
158: 915-920
[Abstract][Full Text]
Strina, A., Cairncross, S., Barreto, M. L., Larrea, C., Prado, M. S.
(2003). Childhood Diarrhea and Observed Hygiene Behavior in Salvador, Brazil. Am J Epidemiol
157: 1032-1038
[Abstract][Full Text]
Ray, W A, Daugherty, J R, Griffin, M R
(2002). Lipid-lowering agents and the risk of hip fracture in a Medicaid population. Inj. Prev.
8: 276-279
[Abstract][Full Text]
Cramer, J. A
(2002). Effect of partial compliance on cardiovascular medication effectiveness. Heart
88: 203-206
[Full Text]
Kaptchuk, T. J.
(2002). The Placebo Effect in Alternative Medicine: Can the Performance of a Healing Ritual Have Clinical Significance?. ANN INTERN MED
136: 817-825
[Abstract][Full Text]
Furberg, C. D
(2002). To whom do the research findings apply?. Heart
87: 570-574
[Full Text]
HUJOEL, P.P.
(2002). Does chronic periodontitis cause coronary heart disease?: A review of the literature. Journal of the American Dental Association
133: 31S-36S
[Abstract][Full Text]
Grady, D.
(2002). A 60-Year-Old Woman Trying to Discontinue Hormone Replacement Therapy. JAMA
287: 2130-2137
[Full Text]
Dormandy, J.
(2002). The need for outcome studies in type 2 diabetes. British Journal of Diabetes & Vascular Disease
2: S32-S36
[Abstract]
Shlipak, M. G., Angeja, B. G., Go, A. S., Frederick, P. D., Canto, J. G., Grady, D.
(2001). Hormone Therapy and In-Hospital Survival After Myocardial Infarction in Postmenopausal Women. Circulation
104: 2300-2304
[Abstract][Full Text]
Montori, V. M., Guyatt, G. H.
(2001). Intention-to-treat principle. CMAJ
165: 1339-1341
[Full Text]
McPherson, K, Britton, A
(2001). Preferences and understanding their effects on health. Qual Saf Health Care
10: i61-66
[Abstract][Full Text]
Juni, P., Altman, D. G, Egger, M.
(2001). Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ
323: 42-46
[Full Text]
Grady, D., Hulley, S. B.
(2001). Postmenopausal hormones and heart disease. J Am Coll Cardiol
38: 8-10
[Full Text]
Bhandari, M., Guyatt, G. H., Swiontkowski, M. F.
(2001). User's Guide to the Orthopaedic Literature: How to Use an Article About a Surgical Therapy. JBJS
83: 916-926
[Abstract][Full Text]
Fong, D. S., Ferris III, F. L.
(2001). Evidence-Guided Ophthalmology. Arch Ophthalmol
119: 585-589
[Abstract][Full Text]
Christakis, D. A., Mell, L., Koepsell, T. D., Zimmerman, F. J., Connell, F. A.
(2001). Association of Lower Continuity of Care With Greater Risk of Emergency Department Use and Hospitalization in Children. Pediatrics
107: 524-529
[Abstract][Full Text]
Grady, D., Hulley, S. B.
(2000). Hormones To Prevent Coronary Disease in Women: When Are Observational Studies Adequate Evidence?. ANN INTERN MED
133: 999-1001
[Full Text]
Bedell, S. E., Jabbour, S., Goldberg, R., Glaser, H., Gobble, S., Young-Xu, Y., Graboys, T. B., Ravid, S.
(2000). Discrepancies in the Use of Medications: Their Extent and Predictors in an Outpatient Practice. Arch Intern Med
160: 2129-2134
[Abstract][Full Text]
Ziegelstein, R. C., Fauerbach, J. A., Stevens, S. S., Romanelli, J., Richter, D. P., Bush, D. E.
(2000). Patients With Depression Are Less Likely to Follow Recommendations to Reduce Cardiac Risk During Recovery From a Myocardial Infarction. Arch Intern Med
160: 1818-1823
[Abstract][Full Text]
Ernster, V. L., Barclay, J., Kerlikowske, K., Wilkie, H., Ballard-Barbash, R.
(2000). Mortality Among Women With Ductal Carcinoma In Situ of the Breast in the Population-Based Surveillance, Epidemiology and End Results Program. Arch Intern Med
160: 953-958
[Abstract][Full Text]
Hemminki, E.
(2000). Hormone replacement therapy: discrepancies between evidence and recommendations. Scand J Public Health
28: 81-83
[Abstract]
Hollis, S., Campbell, F.
(1999). What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ
319: 670-674
[Abstract][Full Text]
Irvine, J., Baker, B., Smith, J., Jandciu, S., Paquette, M., Cairns, J., Connolly, S., Roberts, R., Gent, M., Dorian, P.
(1999). Poor Adherence to Placebo or Amiodarone Therapy Predicts Mortality: Results From the CAMIAT Study. Psychosom. Med.
61: 566-575
[Abstract][Full Text]
Barrett-Connor, E., Stuenkel, C.
(1999). Hormones and Heart Disease in Women: Heart and Estrogen/Progestin Replacement Study in Perspective. J. Clin. Endocrinol. Metab.
84: 1848-1853
[Full Text]
Joseph, L. N., Babikian, V. L., Allen, N. C., Winter, M. R.
(1999). Risk Factor Modification in Stroke Prevention : The Experience of a Stroke Clinic. Stroke
30: 16-20
[Abstract][Full Text]
Ziegelstein, R. C., Bush, D. E., Fauerbach, J. A., McDermott, M. M., Schmitt, B.
(1998). Depression, Adherence Behavior, and Coronary Disease Outcomes. Arch Intern Med
158: 808-809
[Full Text]
McDermott, M. M., Schmitt, B., Wallner, E.
(1997). Impact of Medication Nonadherence on Coronary Heart Disease Outcomes: A Critical Review. Arch Intern Med
157: 1921-1929
[Abstract]
The Standards of Reporting Trials Group, , Andrew, E., Anis, A., Chalmers, T., Cho, M., Clarke, M., Felson, D., Gotzsche, P., Greene, R., Jadad, A., Jonas, W., Klassen, T., Knipschild, P., Laupacis, A., Meinert, C. L., Moher, D., Nichol, G., Oxman, A., Penman, M.-F., Pocock, S., Reisch, J., Sackett, D., Schulz, K., Snider, J., Tugwell, P., Tyson, J., Varin, F., Walop, W., Walsh, S., Wells, G.
(1994). A Proposal for Structured Reporting of Randomized Controlled Trials. JAMA
272: 1926-1931
[Abstract]
Glynn, R. J., Buring, J. E., Manson, J. E., LaMotte, F., Hennekens, C. H.
(1994). Adherence to Aspirin in the Prevention of Myocardial Infarction: The Physicians' Health Study. Arch Intern Med
154: 2649-2657
[Abstract]
Turner, J. A., Deyo, R. A., Loeser, J. D., Von Korff, M., Fordyce, W. E.
(1994). The Importance of Placebo Effects in Pain Treatment and Research. JAMA
271: 1609-1614
[Abstract]
Guyatt, G. H., Sackett, D. L., Cook, D. J., the Evidence-Based Medicine Working Group, , Guyatt, G., Bass, E., Brill-Edwards, P., Browman, G., Cook, D., Farkouh, M., Gerstein, H., Haynes, B., Hayward, R., Holbrook, A., Jaeschke, R., Juniper, E., Laupacis, A., Lee, H., Levine, M., Moyer, V., Nishikawa, J., Oxman, A., Patel, A., Philbrick, J., Richardson, W. S., Sauve, S., Sackett, D., Sinclair, J., Trout, K. S., Tugwell, P., Tunis, S., Walter, S., Williams, J. Jr, Wilson, M.
(1993). Users' Guides to the Medical Literature: II. How to Use an Article About Therapy or Prevention A. Are the Results of the Study Valid?. JAMA
270: 2598-2601
[Abstract]
Horwitz, R. I., Horwitz, S. M.
(1993). Adherence to Treatment and Health Outcomes. Arch Intern Med
153: 1863-1868
[Abstract]
Gallagher, E. J., Viscoli, C. M., Horwitz, R. I.
(1993). The Relationship of Treatment Adherence to the Risk of Death After Myocardial Infarction in Women. JAMA
270: 742-744
[Abstract]
Bennett, J. C., The Board on Health Sciences Policy of the Institu,
(1993). Inclusion of Women in Clinical Trials -- Policies for Population Subgroups. NEJM
329: 288-292
[Full Text]
Barrett-Connor, E.
(1991). Postmenopausal Estrogen and Prevention Bias. ANN INTERN MED
115: 455-456
[Abstract]
Yusuf, S., Wittes, J., Probstfield, J., Tyroler, H. A.
(1991). Analysis and Interpretation of Treatment Effects in Subgroups of Patients in Randomized Clinical Trials. JAMA
266: 93-98
[Abstract]
Barrett-Connor, E., Bush, T. L.
(1991). Estrogen and Coronary Heart Disease in Women. JAMA
265: 1861-1867
[Abstract]
Chalmers, T. C., Frank, C. S., Reitman, D.
(1990). Minimizing the Three Stages of Publication Bias. JAMA
263: 1392-1395
[Abstract]
Psaty, B. M., Koepsell, T. D., LoGerfo, J. P., Wagner, E. H., Inui, T. S.
(1989). {beta}-Blockers and Primary Prevention of Coronary Heart Disease in Patients With High Blood Pressure. JAMA
261: 2087-2094
[Abstract]
Davidson, R. A., Caranasos, G. J.
(1987). Should the Elderly Hypertensive Be Treated? Evidence From Clinical Trials. Arch Intern Med
147: 1933-1937
[Abstract]
Dalen, J. E., Hirsh, J., Dalen, J. E., Hirsh, J.
(1986). American College of Chest Physicians and the National Heart, Lung, and Blood Institute National Conference on Antithrombotic Therapy. Arch Intern Med
146: 462-472
[Abstract]
Kramer, M. S., Shapiro, S. H.
(1984). Scientific Challenges in the Application of Randomized Trials. JAMA
252: 2739-2745
[Abstract]
Lipid Research Clinics Program,
(1984). The Lipid Research Clinics Coronary Primary Prevention Trial Results: II. The Relationship of Reduction in Incidence of Coronary Heart Disease to Cholesterol Lowering. JAMA
251: 365-374
[Abstract]
(1983). Intermittent Positive Pressure Breathing Therapy of Chronic Obstructive Pulmonary Disease: A Clinical Trial. ANN INTERN MED
99: 612-620
[Abstract]
FEINSTEIN, A. R.
(1983). An Additional Basic Science for Clinical Medicine: II. The Limitations of Randomized Trials. ANN INTERN MED
99: 544-550
[Abstract]
RESEARCH DEVELOPMENT COMMITTEE,
(1983). Clinical Research Methods: An Annotated Bibliography. ANN INTERN MED
99: 419-424
[Abstract]
Lew, R. A., Day, C. L. Jr, Harrist, T. J., Wood, W. C., Mihm, M. C. Jr
(1983). Multivariate Analysis: Some Guidelines for Physicians. JAMA
249: 641-643
[Abstract]
BRODY, H.
(1982). The Lie That Heals: The Ethics of Giving Placebos. ANN INTERN MED
97: 112-118
[Abstract]
Greenspan, S. I., Sharfstein, S. S.
(1981). Efficacy of Psychotherapy: Asking the Right Questions. Arch Gen Psychiatry
38: 1213-1219
[Abstract]
Previous
